Abbott (ABT) Provides Details on Restructuring Plan for Solvay's Pharma Unit; Sees Q3 Charge of $430M

Go back to Abbott (ABT) Provides Details on Restructuring Plan for Solvay's Pharma Unit; Sees Q3 Charge of $430M